KA
AGN

Kovack Advisors’s Allergan plc AGN Stock Holding History

Kovack Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5
Closed -$4K – 524
2019
Q1 		$4K Hold
5
– – ﹤0.01% 437
2018
Q4 		$9K Buy
+5
New +$820 ﹤0.01% 407
2017
Q4 		– Sell
-5
Closed -$5K – 505
2017
Q3 		$5K Buy
+5
New +$1.16K ﹤0.01% 345

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Kovack Advisors's AGN Position: Q2 2019 in Review

Kovack Advisors sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 1,903 shares — an estimated $279K sold.

Kovack Advisors first reported a position in AGN in Q4 2014 and held it in 18 quarters. The position peaked at $1.46M in Q2 2017. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Kovack Advisors reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Kovack Advisors sold 1,903 Allergan plc shares in Q2 2019, an estimated $279K.
  • Kovack Advisors first reported a position in Allergan plc in Q4 2014 and held it in 18 quarters.
  • Kovack Advisors's Allergan plc position peaked at $1.46M in Q2 2017.
  • 970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Kovack Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.